164 related articles for article (PubMed ID: 16100689)
1. British Pharmacological Society Cambridge Symposia. 5-7 January 2000, Cambridge, UK.
Lawson K
IDrugs; 2000 Apr; 3(4):373-6. PubMed ID: 16100689
[TBL] [Abstract][Full Text] [Related]
2. British Pharmacological Society Cambridge Symposia. Pharmacology for the next millennium. 5-7 January 2000, Cambridge, UK.
Chazot P
IDrugs; 2000 Apr; 3(4):377-8. PubMed ID: 16100690
[TBL] [Abstract][Full Text] [Related]
3. The British Pharmacological Society--winter meeting. Neuropharmacology. 6-8 January 1999, Brighton, UK.
Chazot P
IDrugs; 1999 Mar; 2(3):214-6. PubMed ID: 16160928
[TBL] [Abstract][Full Text] [Related]
4. International Behavioral Neuroscience Society - ninth annual meeting.
Agmo A
IDrugs; 2000 Jul; 3(7):743-4. PubMed ID: 16080041
[TBL] [Abstract][Full Text] [Related]
5. British Pharmacological Society--summer meeting.
Chazot P
IDrugs; 1999 Oct; 2(10):974-6. PubMed ID: 16118700
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids.
Lawson K
IDrugs; 1999 Oct; 2(10):977-9. PubMed ID: 16118701
[TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid system: current pharmacological research and therapeutic possibilities.
Jonsson KO; Holt S; Fowler CJ
Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):124-34. PubMed ID: 16445584
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
Burns TL; Ineck JR
Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552
[TBL] [Abstract][Full Text] [Related]
9. European Neuroendocrine Association--ninth meeting. 3-7 September 1999, Odense, Denmark.
Almeida OF
IDrugs; 1999 Dec; 2(12):1271-4. PubMed ID: 16113954
[TBL] [Abstract][Full Text] [Related]
10. Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart.
Hajrasouliha AR; Tavakoli S; Ghasemi M; Jabehdar-Maralani P; Sadeghipour H; Ebrahimi F; Dehpour AR
Eur J Pharmacol; 2008 Jan; 579(1-3):246-52. PubMed ID: 17950273
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptors in atherosclerosis.
Steffens S; Mach F
Curr Opin Lipidol; 2006 Oct; 17(5):519-26. PubMed ID: 16960500
[TBL] [Abstract][Full Text] [Related]
12. CB2 cannabinoid receptor mediation of antinociception.
Ibrahim MM; Rude ML; Stagg NJ; Mata HP; Lai J; Vanderah TW; Porreca F; Buckley NE; Makriyannis A; Malan TP
Pain; 2006 May; 122(1-2):36-42. PubMed ID: 16563625
[TBL] [Abstract][Full Text] [Related]
13. RSC-SCI--tenth medicinal chemistry symposium. 5-8 September 1999, Churchill College, Cambridge, UK.
Cliffe IA; Bebbington D; Gillespie RJ; Knutsen LJ
IDrugs; 1999 Nov; 2(11):1122-5. PubMed ID: 16113979
[TBL] [Abstract][Full Text] [Related]
14. American Society of Hematology--40th annual meeting. 4-8 December 1998, Miami Beach, FL, USA.
Greengard JS
IDrugs; 1999 Feb; 2(2):94-6. PubMed ID: 16160942
[TBL] [Abstract][Full Text] [Related]
15. [The cannabinoid system and pain: a new therapeutic avenue?].
Desroches J; Beaulieu P
Rev Med Suisse; 2008 Jun; 4(162):1505-6, 1508-10, 1512-3. PubMed ID: 18649597
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological FMRI in the development of new analgesic compounds.
Schweinhardt P; Bountra C; Tracey I
NMR Biomed; 2006 Oct; 19(6):702-11. PubMed ID: 16986120
[TBL] [Abstract][Full Text] [Related]
17. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.
Yao BB; Hsieh G; Daza AV; Fan Y; Grayson GK; Garrison TR; El Kouhen O; Hooker BA; Pai M; Wensink EJ; Salyers AK; Chandran P; Zhu CZ; Zhong C; Ryther K; Gallagher ME; Chin CL; Tovcimak AE; Hradil VP; Fox GB; Dart MJ; Honore P; Meyer MD
J Pharmacol Exp Ther; 2009 Jan; 328(1):141-51. PubMed ID: 18931146
[TBL] [Abstract][Full Text] [Related]
19. American Society of Gene Therapy--second annual meeting. 9-13 June 1999, Washington DC, USA.
Palmer K
IDrugs; 1999 Aug; 2(8):741-4. PubMed ID: 16127643
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects.
Izzo AA; Camilleri M
Gut; 2008 Aug; 57(8):1140-55. PubMed ID: 18397936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
